PYRITHIONE ZINC

US Approved OTC

First approved in 1961

Details

Stereochemistry	ACHIRAL
Molecular Formula	2C5H4NOS.Zn
Molecular Weight	317.722
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

[Zn++].[O-][N+]1=CC=CC=C1[S-].[O-][N+]2=CC=CC=C2[S-]

InChI

InChIKey=OTPSWLRZXRHDNX-UHFFFAOYSA-L

InChI=1S/2C5H5NOS.Zn/c2*7-6-4-2-1-3-5(6)8;/h2*1-4,8H;/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula	C5H5NOS
Molecular Weight	127.164
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	Zn
Molecular Weight	65.409
Charge	2
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/15685130 | https://www.drugs.com/cdi/pyrithione-zinc-shampoo.html | https://www.dermaharmony.com/ingredients/pyrithionezinc.aspx | https://www.ncbi.nlm.nih.gov/pubmed/26885780

Pyrithione zinc is an antibacterial and antifungal agent developed by scientists in the 1930's. Since then it has been used to treat seborrheic dermatitis of the scalp and other skin conditions such as eczema, athlete's foot, and vitiligo, as well as psoriasis. Because of its antifungal properties, it is commonly found in dandruff shampoo. Products containing pyrithione zinc are available today with and without prescription, and it is the main ingredient in many over-the-counter creams, lotions, soaps, and shampoos. It also has antibacterial properties and is effective against many pathogens from the Streptococcus and Staphylococcus genera. Pyrithione zinc`s other medical applications include treatments of psoriasis, eczema, ringworm, fungus, athletes foot, dry skin, atopic dermatitis, tinea, and vitiligo. Its antifungal effect is thought to derive from its ability to disrupt membrane transport by blocking the proton pump that energizes the transport mechanism.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Potency
Egl nine homolog 3 19 Target ID: CHEMBL5705 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26940742	Inhibitor 8297	0.98 µM [IC50]
transformed cell apoptotic process 108 Target ID: GO:0006927 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22105358	Activator 1430
Hypoxia-inducible factor 1 alpha 17 Target ID: CHEMBL4261 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20473380	Activator 1430

Conditions

Condition	Modality	Targets	Highest Phase	Product
Seborrhea 11 Sources: https://www.drugs.com/cdi/pyrithione-zinc-shampoo.html https://www.ncbi.nlm.nih.gov/pubmed/26885780 https://www.ncbi.nlm.nih.gov/pubmed/22866664	Curative		Approved 8429	Pyrithione zinc shampoo Approved Use Pyrithione zinc shampoo is used for: Treating and preventing itching, flaking, and scaling of the scalp caused by dandruff or seborrhea (oily, crusting, or scaling skin). Pyrithione zinc shampoo is an antiseborrheic. It works by slowing the production of skin cells, which helps to reduce flakiness. Launch Date 5.10796792E11
Acute myeloid leukemia 136 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22105358	Primary		Preclinical	Unknown Approved Use Unknown

C_max

Value	Dose	Co-administered	Analyte	Population
0.2 μg/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/730082/	0.5 mg/kg single, oral dose: 0.5 mg/kg route of administration: Oral experiment type: SINGLE co-administered:		PYRITHIONE plasma	Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED

AUC

Value	Dose	Co-administered	Analyte	Population
27.01 μg × h/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/730082/	0.5 mg/kg single, oral dose: 0.5 mg/kg route of administration: Oral experiment type: SINGLE co-administered:		PYRITHIONE plasma	Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED

T_1/2

Value	Dose	Co-administered	Analyte	Population
115 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/730082/	0.5 mg/kg single, oral dose: 0.5 mg/kg route of administration: Oral experiment type: SINGLE co-administered:		PYRITHIONE plasma	Rattus norvegicus population: HEALTHY age: ADULT sex: MALE food status: FASTED

Doses

Dose	Population	Adverse events
1 % 2 times / week multiple, topical Recommended Dose: 1 %, 2 times / week Route: topical Route: multiple Dose: 1 %, 2 times / week Sources: https://pubmed.ncbi.nlm.nih.gov/12476017 Page: p.436, 438	unhealthy, 17–64 n = 160 Health Status: unhealthy Condition: Severe dandruff \|Seborrheic dermatitis Age Group: 17–64 Sex: M+F Population Size: 160 Sources: https://pubmed.ncbi.nlm.nih.gov/12476017 Page: p.436, 438	Disc. AE: Erythema... AEs leading to discontinuation/dose reduction: Erythema (1.25%) Sources: https://pubmed.ncbi.nlm.nih.gov/12476017 Page: p.436, 438

AEs

AE	Significance	Dose	Population
Erythema	1.25% Disc. AE	1 % 2 times / week multiple, topical Recommended Dose: 1 %, 2 times / week Route: topical Route: multiple Dose: 1 %, 2 times / week Sources: https://pubmed.ncbi.nlm.nih.gov/12476017 Page: p.436, 438	unhealthy, 17–64 n = 160 Health Status: unhealthy Condition: Severe dandruff \|Seborrheic dermatitis Age Group: 17–64 Sex: M+F Population Size: 160 Sources: https://pubmed.ncbi.nlm.nih.gov/12476017 Page: p.436, 438

Overview

CYP3A4	CYP2C9	CYP2D6	hERG
			inhibitor 1612

OverviewOther

Other Inhibitor	Other Substrate	Other Inducer

Tox targets

Target	Modality	Activity	Metabolite	Clinical evidence
hERG 1647	inhibitor 1626 Sources: https://pubmed.ncbi.nlm.nih.gov/21362439/

Sourcing

Vendor/Aggregator	ID	URL
ChEBI	CHEBI:36578	https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:36578
ChemicalBook	CB8889373	https://www.chemicalbook.com/ChemicalProductProperty_EN_CB8889373
MolPort	MolPort-006-148-004	https://www.molport.com/shop/molecule-link/MolPort-006-148-004
ZINC	ZINC000013524343	http://zinc15.docking.org/substances/ZINC000013524343

PubMed

Title	Date	PubMed
Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling.	2003 Dec 10	14644152
Non-toxic antifouling activity of polymeric 3-alkylpyridinium salts from the Mediterranean sponge Reniera sarai (Pulitzer-Finali).	2003 Feb	14618688
Effect of Zn2+ ions on ryanodine binding to sarcoplasmic reticulum of striated muscles in the presence of pyrithione.	2004 Dec	15569410
Chromatographic behavior of pyrithiones.	2004 Oct 15	15527126
Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV.	2004 Sep 10	15358550
Activation of a calcium entry pathway by sodium pyrithione in the bag cell neurons of Aplysia.	2004 Sep 15	15307146
A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos.	2005 Dec	16382664
Product pharmacology and medical actives in achieving therapeutic benefits.	2005 Dec	16382663
S100A9 deficiency alters adenosine-5'-triphosphate induced calcium signalling but does not generally interfere with calcium and zinc homeostasis in murine neutrophils.	2005 Jun	15778088
Reaction of hydroxyl radical with aromatic hydrocarbons in nonaqueous solutions: A laser flash photolysis study in acetonitrile.	2005 Mar 24	16833557
Endogenous zinc in neurological diseases.	2005 Oct	20396459
3-Alkylpyridinium compounds as potential non-toxic antifouling agents.	2006	16805440
Unconventional neuroprotection against Ca2+ -dependent insults by metalloporphyrin catalytic antioxidants.	2006 Aug	16895586
The interactive effects of binary mixtures of three antifouling biocides and three heavy metals against the marine algae Chaetoceros gracilis.	2006 Aug	16841316
Toxicity reduction of metal pyrithiones by near ultraviolet irradiation.	2006 Aug	16841307
Inhibition of presynaptic activity by zinc released from mossy fiber terminals during tetanic stimulation.	2006 Jan	16342122
Flow cytometric measurement of labile zinc in peripheral blood mononuclear cells.	2006 May 15	16545333
Acute toxicity of pyrithione antifouling biocides and joint toxicity with copper to red sea bream (Pagrus major) and toy shrimp (Heptacarpus futilirostris).	2006 Nov	17089732
Zinc induces ERK-dependent cell death through a specific Ras isoform.	2006 Nov	17013754
Overexpression of DSCR1 blocks zinc-induced neuronal cell death through the formation of nuclear aggregates.	2007 Aug	17596961
Automated laser scanning cytometry: a powerful tool for multi-parameter analysis of drug-induced apoptosis.	2007 Feb	17200953
Chemical genetics suggests a critical role for lysyl oxidase in zebrafish notochord morphogenesis.	2007 Jan	17216056
Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms.	2007 May	17322024
Role of zinc influx via AMPA/kainate receptor activation in metabotropic glutamate receptor-mediated calcium release.	2007 May 1	17304583
Toxicity of four antifouling biocides and their mixtures on the brine shrimp Artemia salina.	2007 Nov 15	17765949
2-(Benzyl-sulfan-yl)pyridine N-oxide.	2008 Apr 26	21202409
Poly[ethano-lbis(μ(3)-2-thio-xo-1,2-dihydro-pyridin-1-olato)dilithium(I)].	2008 Feb 8	21201855
Thioperoxy derivative generated by UV-induced transformation of N-hydroxypyridine-2(1H)-thione isolated in low-temperature matrixes.	2008 Jan 17	18085761
2,2'-[2,3,5,6-Tetra-methyl-p-phenyl-ene-bis(methyl-enethio)]bis-(pyridine N-oxide).	2008 Jan 9	21201437
Synthesis and anticancer properties of water-soluble zinc ionophores.	2008 Jul 1	18593933
Aryl-bridged 1-hydroxypyridin-2-one: sensitizer ligands for Eu(III).	2008 Jul 21	18553909
2-(Mesitylmethylsulfanyl)pyridine N-oxide monohydrate.	2008 Sep 17	21201156
2-(2,3,5,6-Tetra-methyl-benzyl-sulfan-yl)pyridine N-oxide.	2008 Sep 20	21201175
Molecular mechanism underlying Akt activation in zinc-induced cardioprotection.	2009 Aug	19525380
Rising zinc: a significant cause of ischemic neuronal death in the CA1 region of rat hippocampus.	2009 Aug	19491923
Electrospray ionization mass spectrometric observation of ligand exchange of zinc pyrithione with amino acids.	2009 Jul	19517459
Clioquinol and pyrithione activate TRPA1 by increasing intracellular Zn2+.	2009 May 19	19416844
Metal ionophores - an emerging class of anticancer drugs.	2009 Nov	19859983
Tracing of intracellular zinc(II) fluorescence flux to monitor cell apoptosis by using FluoZin-3AM.	2009 Oct	19784961
Pyrithione and 8-hydroxyquinolines transport lead across erythrocyte membranes.	2009 Sep	19665691
Dandruff: the most commercially exploited skin disease.	2010 Apr-Jun	20606879
Activation of the orphan receptor tyrosine kinase ALK by zinc.	2010 Aug 6	20621063
The roles of iPLA2, TRPM8 and TRPA1 in chemically induced cold hypersensitivity.	2010 Jan 21	20092626
DNA microarray analysis suggests that zinc pyrithione causes iron starvation to the yeast Saccharomyces cerevisiae.	2010 May	20347771
Cellular zinc homeostasis is a regulator in monocyte differentiation of HL-60 cells by 1 alpha,25-dihydroxyvitamin D3.	2010 May	20089671
K+ channel openers restore verapamil-inhibited lung fluid resolution and transepithelial ion transport.	2010 May 27	20507598
Novel antifouling agent zinc pyrithione: determination, acute toxicity, and bioaccumulation in marine mussels (Mytilus galloprovincialis).	2010 Nov	20853456
Zinc in innate and adaptive tumor immunity.	2010 Nov 18	21087493
Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture.	2010 Nov 4	21079686
UVB radiation induces an increase in intracellular zinc in human epidermal keratinocytes.	2010 Oct	20818483

Patents

Sample Use Guides

In Vivo Use Guide

Shake well before each use. Wet hair thoroughly. Apply pyrithione zinc shampoo and work into a lather. Rinse thoroughly and repeat. For best results, use pyrithione zinc shampoo at least 2 times per week or as directed by your doctor. Do not use more often than once daily.

Route of Administration: Topical

In Vitro Use Guide

Pyrithione zinc had a reversible inhibitory effect on the growth of BHK 21 cells at 0.1 ug/ml, but had a rapid, irreversible inhibitory effect at 1 ug/ml associated with cell rounding and detachment.

Substance Class	Chemical Created by `admin` on `Fri Dec 15 15:05:25 UTC 2023` Edited by `admin` on `Fri Dec 15 15:05:25 UTC 2023`
Record UNII	R953O2RHZ5
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PYRITHIONE ZINC

Official Name

English

ZINC PYRITHIONE

Official Name

English

ZINC PYRITHONE [VANDF]

Common Name

English

ZINC PYRIDINETHIONE

Common Name

English

pyrithione zinc [INN]

Common Name

English

PYRITHIONE ZINC DERIVATIVE [MI]

Common Name

English

SEBULON SHAMPOO

Brand Name

English

NSC-290409

Code

English

PYRITHIONE ZINC DERIVATIVE

Common Name

English

PYRITHIONE ZINC [MART.]

Common Name

English

ZINC PYRITHIONE [JAN]

Common Name

English

ZINC PYRITHIONE [VANDF]

Common Name

English

PYRITHIONE ZINC [VANDF]

Common Name

English

ZINC OMADINE

Common Name

English

ZINC-2-PYRIDINETHIONE-1-OXIDE

Systematic Name

English

Bis[1-hydroxy-2(1H)-pyridinethionato]zinc

Common Name

English

ZINC PYRITHIONE [INCI]

Common Name

English

HEAD & SHOULDERS CONDITIONER

Brand Name

English

PYRITHIONE ZINC [USAN]

Common Name

English

ZINC, BIS(1-(HYDROXY-.KAPPA.O)-2(1H)-PYRIDINETHIONATO-.KAPPA.S2)-, (T-4)-

Systematic Name

English

ZINC PYRITHIONE [HSDB]

Common Name

English

PYRITHIONE ZINC [ORANGE BOOK]

Common Name

English

Pyrithione zinc [WHO-DD]

Common Name

English

ZINCPOLYANEMINE

Common Name

English

ZINC, BIS(1-HYDROXY-2(1H)-PYRIDINETHIONATO-O,S)-(T-4)-

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C514